Search by Drug Name or NDC
NDC 50090-2558-02 Mirtazapine 30 mg/1 Details
Mirtazapine 30 mg/1
Mirtazapine is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by A-S Medication Solutions. The primary component is MIRTAZAPINE.
MedlinePlus Drug Summary
Mirtazapine is used to treat depression. Mirtazapine is in a class of medications called antidepressants. It works by increasing certain types of activity in the brain to maintain mental balance.
Related Packages: 50090-2558-02Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Mirtazapine
Product Information
| NDC | 50090-2558 |
|---|---|
| Product ID | 50090-2558_39aea0f8-fc6c-444d-9733-b2b8f2a1075a |
| Associated GPIs | 58030050000330 |
| GCN Sequence Number | 046451 |
| GCN Sequence Number Description | mirtazapine TABLET 30 MG ORAL |
| HIC3 | H7B |
| HIC3 Description | ALPHA-2 RECEPTOR ANTAGONIST ANTIDEPRESSANTS |
| GCN | 16733 |
| HICL Sequence Number | 011505 |
| HICL Sequence Number Description | MIRTAZAPINE |
| Brand/Generic | Generic |
| Proprietary Name | Mirtazapine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Mirtazapine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 30 |
| Active Ingredient Units | mg/1 |
| Substance Name | MIRTAZAPINE |
| Labeler Name | A-S Medication Solutions |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA076921 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50090-2558-02 (50090255802)
| NDC Package Code | 50090-2558-2 |
|---|---|
| Billing NDC | 50090255802 |
| Package | 60 TABLET, FILM COATED in 1 BOTTLE (50090-2558-2) |
| Marketing Start Date | 2016-12-16 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |